Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer

被引:23
|
作者
Ji, Huihui [1 ]
Zhang, Jian-an [1 ]
Liu, Hejing [1 ]
Li, Kehan [1 ]
Wang, Zhi-wei [1 ]
Zhu, Xueqiong [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Ctr Uterine Canc Diag & Therapy Res Zhejiang Prov, Dept Obstet & Gynecol, Wenzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
cervical cancer; M6A; TME; PD-1; PD-L1; TIME; MESSENGER-RNA; CELLS;
D O I
10.3389/fimmu.2022.976107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Understanding the role of N6-adenosine methylation (m6A) in the tumor microenvironment (TME) is important since it can contribute to tumor development. However, the research investigating the association between m6A and TME and cervical cancer is still in its early stages. The aim of this study was to discover the possible relationship between m6A RNA methylation regulators, TME, PD-L1 expression levels, and immune infiltration in cervical cancer. We gathered RNA-seq transcriptome data and clinical information from cervical cancer patients using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. To begin, researchers assessed the differences in m6A regulatory factor expression levels between cervical cancer and normal tissues. Clustering analysis was adapted to assess PD-L1 expression, immunological score, immune cell infiltration, TME, and probable pathways in cervical cancer samples. The majority of m6A regulators were found to be considerably overexpressed in cervical cancer tissues. Using consensus clustering of 21 m6A regulators, we identified two subtypes (clusters 1/2) of cervical cancer, and we found that WHO stage and grade were associated with the subtypes. PD-L1 expression increased dramatically in cervical cancer tissues and was significantly linked to ALKBH5, FTO, METTL3, RBM15B, YTHDF1, YTHDF3, and ZC3H13 expression levels. Plasma cells and regulatory T cells (Tregs) were considerably elevated in cluster 2. Cluster 1 is involved in numerous signature pathways, including basal transcription factors, cell cycle, RNA degradation, and the spliceosome. The prognostic signature-based riskscore (METTL16, YTHDF1, and ZC3H13) was found to be an independent prognostic indicator of cervical cancer. The tumor immune microenvironment (TIME) was linked to m6A methylation regulators, and changes in their copy number will affect the quantity of tumor-infiltrating immune cells dynamically. Overall, our research discovered a powerful predictive signature based on m6A RNA methylation regulators. This signature correctly predicted the prognosis of cervical cancer patients. The m6A methylation regulator could be a critical mediator of PD-L1 expression and immune cell infiltration, and it could have a significant impact on the TIME of cervical cancer.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
    Xu, Yangtao
    He, Xiaoqin
    Deng, Junjian
    Xiong, Lin
    Li, Yue
    Zhang, Xiaoyu
    Chen, Wenliang
    Liu, Xin
    Xu, Ximing
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [2] Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer
    Xu, Zhiyuan
    Chen, Qiuli
    Shu, Lilu
    Zhang, Chunye
    Liu, Wenjun
    Wang, Peter
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma
    Yi, Lilan
    Wu, Guowu
    Guo, Longhua
    Zou, Xiaofang
    Huang, Ping
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 21 : 299 - 314
  • [4] Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
    Guo, Wei
    Tan, Fengwei
    Huai, Qilin
    Wang, Zhen
    Shao, Fei
    Zhang, Guochao
    Yang, Zhenlin
    Li, Renda
    Xue, Qi
    Gao, Shugeng
    He, Jie
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular Carcinoma
    Lin, Yingxue
    Yao, Yinhui
    Wang, Ying
    Wang, Lingdi
    Cui, Haipeng
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [6] Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer
    Guo, Yongdong
    Wang, Ronglin
    Li, Junqiang
    Song, Yang
    Min, Jie
    Zhao, Ting
    Hua, Lei
    Shi, Jingjie
    Zhang, Chao
    Ma, Peixiang
    Yang, Cheng
    Zhu, Liaoliao
    Gan, Dongxue
    Li, Shanshan
    Liu, Xiaonan
    Su, Haichuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma
    Liu, Rui
    Shen, Ying
    Hu, Jinsong
    Wang, Xiaman
    Wu, Dong
    Zhai, Meng
    Bai, Ju
    He, Aili
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer
    Guo, Yilin
    Bai, Yangyang
    Wang, Lu
    Xu, Zhen
    Wang, Xiliang
    Wang, Wuliang
    MEDICINE, 2022, 101 (26) : E29818
  • [9] Effects of m6A RNA methylation regulators on endometrial cancer
    Zhang, Yanli
    Yang, Yingjie
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (09)
  • [10] Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer
    Zhu, Jiaqi
    Jiang, Yun
    Wang, Tianyi
    Wu, Anqi
    Zhou, Tingting
    Zhang, Anping
    Tang, Yijie
    Shen, Zihao
    Wang, Jinjie
    Zhou, Hao
    Shi, Jiahai
    Chen, Jianle
    DISEASE MARKERS, 2022, 2022